| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
aDepartment of Neuroanatomy and Center for Systems Neuroscience Hannover,
bInstitute of Biochemistry, and
cDepartment of Trauma Surgery, Hannover Medical School, Hannover, Germany
Key Words. Dopaminergic neurons • Neural stem cells • Nucleofection • Transfection • Transplantation
Correspondence: Claudia Grothe, Dr. rer. nat., Department of Neuroanatomy, Center of Anatomy, OE 4140 Hannover Medical School, Carl-Neuberg-Strasse 1, D-30623 Hannover, Germany. Telephone: 49-511-532-2896; Fax: 49-511-532-2880; e-mail: grothe.claudia{at}mh-hannover.de
Received on March 24, 2006;
accepted for publication on August 4, 2006.
First published online in STEM CELLS EXPRESS August 10, 2006.
Neuronal progenitor cells (NPCs) play an important role in potential regenerative therapeutic strategies for neurodegenerative diseases, such as Parkinson disease. However, survival of transplanted cells is, as yet, limited, and the identification of grafted cells in situ remains difficult. The use of NPCs could be more effective with regard to a better survival and maturation when transfected with one or more neurotrophic factors. Therefore, we investigated the possibility of transfecting mesencephalic neuronal progenitors with different constructs carrying neurotrophic factors or the expression reporters enhanced green fluorescence protein (EGFP) and red fluorescent protein (DsRed). Different techniques for transfection were compared, and the highest transfection rate of up to 47% was achieved by nucleofection. Mesencephalic neuronal progenitors survived the transfection procedure; 6 hours after transfection, viability was approximately 40%, and the transfected cells differentiated into, for example, tyrosine hydroxylase-positive neurons. Within the group of transfected cells, many progenitors and several neurons were found. To provide the progenitor cells with a neurotrophic factor, different isoforms of fibroblast growth factor-2 were introduced. To follow the behavior of the transfected cells in vitro, functional tests such as the cell viability assay (water-soluble tetrazolium salt assay [WST-1]) and the cell proliferation assay (5-bromo-2'-deoxyuridine-enzyme-linked immunosorbent assay) were performed. In addition, these transfected NPCs were viable after transplantation, expressed tyrosine hydroxylase in vivo, and could easily be detected within the host striatum because of their EGFP expression. This study shows that genetic modification of neural progenitors could provide attractive perspectives for new therapeutic concepts in neurodegenerative diseases.
This article has been cited by other articles:
|
|
 |
|
  L. Hasadsri, J. Kreuter, H. Hattori, T. Iwasaki, and J. M. George Functional Protein Delivery into Neurons Using Polymeric Nanoparticles J. Biol. Chem., March 13, 2009; 284(11): 6972 - 6981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-E. Zaragosi, N. Billon, G. Ailhaud, and C. Dani Nucleofection Is a Valuable Transfection Method for Transient and Stable Transgene Expression in Adipose Tissue-Derived Stem Cells Stem Cells, March 1, 2007; 25(3): 790 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Timmer, K. Cesnulevicius, C. Winkler, J. Kolb, E. Lipokatic-Takacs, J. Jungnickel, and C. Grothe Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion J. Neurosci., January 17, 2007; 27(3): 459 - 471. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
